Effective March 1, 2026, UnitedHealthcare now classifies manipulation under anesthesia (MUA), including spinal manipulation under anesthesia (SMUA) and medication-assisted spinal manipulation (MASM), as unproven and not medically necessary when performed for spine indications. The policy cites consistently low-quality evidence—small, nonrandomized studies, short follow-up, and methodological bias—and professional guidance from ACOEM opposing MUA/MASM for acute, subacute, or chronic low back and cervicothoracic pain. MUA is defined broadly to include procedures performed with general anesthesia, sedation, or local anesthetic by various practitioners, but the proposed mechanism of breaking adhesions is not proven safe or effective. Providers should not expect coverage for spinal MUA/MASM except where explicitly supported elsewhere in the policy.
UnitedHealthcare March 2026 Revision: MUA for Spine Classified as Unproven/Not Medically Necessary
This policy revision (UnitedHealthcare Medical Policy CS075NJ.P) clarifies the status of manipulation under anesthesia (MUA) for spinal conditions, effective 2026-03-01. The document explicitly states that manipulation under anesthesia is considered unproven and not medically necessary for the spine and other listed joints when used for indications other than those explicitly supported elsewhere in the policy. The policy text cites insufficient evidence of efficacy and safety in the peer-reviewed literature as the basis for this determination.
The revision references InterQual® criteria for clinical decision support but makes a clear policy-level determination that spinal MUA lacks consistent, high-quality evidence of benefit, noting methodological limitations across the literature (small sample sizes, lack of controls, inadequate masking). The policy also highlights professional guidance (ACOEM statements) that do not recommend MUA/MASM for acute, subacute, or chronic lower back and cervicothoracic pain due to insufficient evidence.
Definition and Rationale for `manipulation under anesthesia` and SMUA
The policy defines manipulation under anesthesia (MUA) broadly as manual joint or spinal manipulation performed after administration of an anesthetic (including general anesthesia, mild sedation, local anesthetic injection, or oral/inhaled agents). It describes the proposed mechanism — reduced protective reflexes permitting short-lever manipulations, passive stretches, and maneuvers intended to break fibrous adhesions and scar tissue — but explicitly states this theoretical mechanism "has not been proven to be safe or effective in the peer-reviewed literature."
Spinal manipulation under anesthesia (SMUA) is described as typically performed by chiropractors, osteopathic physicians, and orthopedic physicians often in conjunction with an anesthesiologist. The policy emphasizes that despite the range of practitioners and anesthetic techniques used, the evidence base specific to spinal applications is limited and inconclusive.
Evidence Summary: Clinical Studies on SMUA for Low Back and Lumbopelvic Pain
The policy summarizes the evidence base for SMUA in lumbopelvic and low back pain and concludes that studies show negligible or inconsistent improvements and are generally of low methodological quality. It cites multiple examples: a small retrospective review by Taber et al. (2014) of 18 cases showing average ODI improvement but limited by size, lack of control, and short follow-up; a prospective nonrandomized study by Kohlbeck et al. (2005) suggesting short-term benefit over spinal manipulation alone but limited by nonrandom allocation and baseline differences; and a prospective controlled study by Palmieri and Smoyak (2002) with apparent short-term differences that were not statistically or clinically meaningful when examined against accepted minimal clinically important differences.
The policy explicitly notes common methodological weaknesses across studies — small sample sizes, lack of randomization or appropriate controls, potential selection and performance bias, short follow-up periods, and inadequate masking — and concludes there is insufficient evidence to support long-term safety or efficacy of SMUA for low back pain.
Professional Guidance Referenced: ACOEM Recommendations against MUA/MASM
Professional society guidance is incorporated into the policy. The American College of Occupational and Environmental Medicine (ACOEM) is cited twice: the 2016 and 2020 positions conclude that MUA and medication-assisted spinal manipulation (MASM) are not recommended for acute, subacute, or chronic lower back pain and for cervicothoracic pain due to lack of quality evidence specifically evaluating these interventions.
The policy uses these professional recommendations to underscore the overall determination that MUA/MASM lack sufficient supportive evidence, reinforcing the payer's position that such procedures for the spine are unproven and not medically necessary.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.